Weekly Investment Analysts’ Ratings Changes for TScan Therapeutics (TCRX)
Several brokerages have updated their recommendations and price targets on shares of TScan Therapeutics (NASDAQ: TCRX) in the last few weeks: 3/7/2025 – TScan Therapeutics had its price target lowered by analysts at Barclays PLC from $14.00 to $3.00. They now have an “overweight” rating on the stock. 3/6/2025 – TScan Therapeutics had its “buy” […]
Several brokerages have updated their recommendations and price targets on shares of TScan Therapeutics (NASDAQ: TCRX) in the last few weeks: 3/7/2025 – TScan Therapeutics had its price target lowered by analysts at Barclays PLC from $14.00 to $3.00. They now have an “overweight” rating on the stock. 3/6/2025 – TScan Therapeutics had its “buy” […]
